Green Acid Mediated Synthesis of Imidazo[1,2‐a]Pyrimidine–Thiazole/1,3,4‐Thiadiazole Hybrids: Design, Characterization and In‐Vitro Biological Evaluation
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Dinesha P und 8 weiteren Autor:innen. Beteiligte Einrichtung: Organic and Medicinal Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Mangalore, Karnataka, India. Hauptthemen laut MEDLINE: Thiadiazoles, Pyrimidines, Thiazoles, Drug Design. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This work reports the design and development of two series of imine‐linked imidazo[1,2‐ a ]pyrimidine‐thiazole/1,3,4‐thiadiazole derivatives using a molecular hybridization approach as anti‐tubercular agents. A total of thirty‐seven new hybrid compounds (B1‐B37) were synthesized and characterized. One final molecule, B20, was structurally confirmed by single‐crystal x‐ray diffraction analysis. All the final compounds (B1‐B37) were tested for activity against the Mycobacterium tuberculosis H37Rv strain. Compounds B5, B26, and B30 exhibited significant inhibitory effects, with MICs of 12.5, 12.5, and 6.25 µg/mL, respectively. All novel final compounds also displayed effective antibacterial action against four bacterial strains S. aureus , E. coli , B. subtilis , and P. aeruginosa . Toxicity tests on mouse fibroblast (L929) cell lines revealed that the highly active anti‐TB compounds (B5, B26, and B30) were nontoxic. Furthermore, the outcomes of the in silico ADME evaluation, DFT analysis, molecular docking studies (targeting CYP121 and InhA), and dynamic simulation demonstrated the potent compounds' great potential as prospective scaffolds for the development of novel antitubercular drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organic and Medicinal Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Mangalore, Karnataka, India.
- School of Sciences, Woxsen University, Hyderabad, India.
- Nitte (Deemed to Be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Chemistry, Mangalore, Karnataka, India.
- Department of Chemistry, Central University of Karnataka, Kalaburagi, Karnataka, India.
ORCID-Profile: Shivakumar Naik, Udayakumar D, Sampat Parayya Vibhutimath, Rajkumar Reddy Rajula, Revanasiddappa B C, Nanditha Bhat, Naveena S Veeranagaiah
Zitieren
APA
P, D., Naik, S., D, U., Dhekale, M. S., Vibhutimath, S. P., Rajula, R. R., B C, R., Bhat, N., & Veeranagaiah, N. S. (2026). Green Acid Mediated Synthesis of Imidazo[1,2‐a]Pyrimidine–Thiazole/1,3,4‐Thiadiazole Hybrids: Design, Characterization and In‐Vitro Biological Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71857
Vancouver
P D, Naik S, D U, Dhekale MS, Vibhutimath SP, Rajula RR, et al. Green Acid Mediated Synthesis of Imidazo[1,2‐a]Pyrimidine–Thiazole/1,3,4‐Thiadiazole Hybrids: Design, Characterization and In‐Vitro Biological Evaluation. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71857
BibTeX
@article{P2026,
author = {P, Dinesha and Naik, Shivakumar and D, Udayakumar and Dhekale, Maithilee S and Vibhutimath, Sampat Parayya and Rajula, Rajkumar Reddy and B C, Revanasiddappa and Bhat, Nanditha and Veeranagaiah, Naveena S},
title = {Green Acid Mediated Synthesis of Imidazo[1,2‐a]Pyrimidine–Thiazole/1,3,4‐Thiadiazole Hybrids: Design, Characterization and In‐Vitro Biological Evaluation},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71857}
}
EUVIMED